George D. Yancopoulos

2012

In 2012, George D. Yancopoulos earned a total compensation of $81.6M as President, Regeneron Laboratories and Chief Scientific Officer at Regeneron Pharmaceuticals, a 713% increase compared to previous year.

Compensation breakdown

Bonus$1,955,000
Option Awards$21,442,383
Salary$850,000
Stock Awards$57,275,000
Other$29,065
Total$81,551,448

Yancopoulos received $57.3M in stock awards, accounting for 70.23% of the total pay in 2012.

Yancopoulos also received $2M in bonus, $21.4M in option awards, $850K in salary and $29.1K in other compensation.

Rankings

In 2012, George D. Yancopoulos' compensation ranked 3rd out of 11,364 executives tracked by ExecPay.

ClassificationRankingPercentile
All
3
out of 11,364
100th
Division
Manufacturing
2
out of 4,199
100th
Major group
Chemicals And Allied Products
1
out of 1,150
100th
Industry group
Drugs
1
out of 888
100th
Industry
Pharmaceutical Preparations
1
out of 669
100th
Source: SEC filing on April 21, 2015.

Yancopoulos' colleagues

We found four more compensation records of executives who worked with George D. Yancopoulos at Regeneron Pharmaceuticals in 2012.

2012

Leonard Schleifer

Regeneron Pharmaceuticals

Chief Executive Officer

2012

Neil Stahl

Regeneron Pharmaceuticals

Executive Vice President, Research & Development

2012

Murray Goldberg

Regeneron Pharmaceuticals

Chief Financial Officer

2012

Robert Terifay

Regeneron Pharmaceuticals

Senior Vice President, Commercial

News

You may also like